Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Diabeloop logo — Medtech seeking to reduce the mental burden associated with...

Diabeloop

Medtech seeking to reduce the mental burden associated with diabetes thanks to interoperable self-learning solutions⚡

Founded 2015 France France 106 employees Venture round Total: $132.29M Health Care, Medical Devices

General Information

Company Name Diabeloop
Founded Year 2015
Location France France
Founders / Decision Makers
Team member
Employees 106
Industries Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Diabeloop. To contact Diabeloop, visit diabeloop.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Diabeloop compare?

A PDF of Diabeloop and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Diabeloop soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Diabeloop

Diabeloop is a medtech startup founded in 2015 and headquartered in France. The company aims to alleviate the mental burden associated with diabetes through interoperable self-learning solutions. Diabeloop's focus is on providing an intelligent therapeutic system for regulating blood glucose. The project originated in 2011 with the collaboration of the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) and the CEA LETI. Following successful clinical trials in 2014, Diabeloop was created to bring the project to market and make it accessible to a wider audience. In spring 2021, Diabeloop launched its first automated insulin delivery device, the DBLG1 System, in multiple European countries including Germany, Italy, Spain, Switzerland, the Netherlands, and France. The latest funding round on 04 March 2024 amounted to €15.00M and was secured from a consortium of investors including Innovacom, Kreaxi, Crédit Agricole, LBO France, Odyssée Venture, Supernova Invest, UI Investissement, テルモ（株）, CERITD, and Cemag Invest. Diabeloop's innovative approach to diabetes management and its successful market entry make it a promising player in the health care and medical devices industries.

Business keywords: Medtech, Diabetes management, Closed-loop system, Medical device, Automated insulin delivery, Artificial intelligence, Disruptive innovation

Services & Products

Development and commercialization of AI-powered medical devices for diabetes management

Target Customers

Patients with Type 1 and Type 2 diabetes healthcare providers international partners

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €15.00M 10
Innovacom Kreaxi Crédit Agricole
Innovacom, Kreaxi +8
04 Mar 2024
Series C €70.00M 10
Innovacom Kreaxi Crédit Agricole
Innovacom, Kreaxi +8
02 Jun 2022
Debt Financing Undisclosed 1
Bpifrance
Bpifrance
02 Jun 2022
Series B €31.00M 7
Kreaxi Odyssée Venture Sofimac Innovation
Kreaxi, Odyssée Venture +5
02 Dec 2019
Grant €2.79M 1
EASME - EU Executive Agency for SMEs
01 Jan 2019
Series A €13.50M 4
Kreaxi Crédit Agricole Sofimac Investment Managers
Kreaxi, Crédit Agricole +2
19 Sep 2017

Diabeloop Alternatives & Competitors

View All Alternatives
Diabeloop vs
MicroTech Medical
MicroTech Medical China

We are dedicated to helping people with diabetes lead a healthy life.

Series D
43 employees
Health Care, Manufacturing
Compare Diabeloop vs MicroTech Medical
Diabeloop vs
Valeritas
Valeritas United States

Improving health and simplifying life for people with diabetes.

Venture round
35 employees
Biotechnology, Health Care
Compare Diabeloop vs Valeritas
Diabeloop vs
HME Square
HME Square Korea South

We listen to your glucose.

Seed
10 employees
Health Care, Medical Devices
View all alternatives

FAQ About Diabeloop

Medtech seeking to reduce the mental burden associated with diabetes thanks to interoperable self-learning solutions⚡
Diabeloop was founded in 2015.
Diabeloop is headquartered in France.
Diabeloop operates in Health Care and Medical Devices. Its work centres on Medtech, Diabetes management, Closed-loop system and Medical device. Its customers include Patients with Type 1 and Type 2 diabetes, healthcare providers and international partners.
Diabeloop has approximately 106 employees.
Diabeloop has completed 6 funding rounds, raising a total of $132.29M. The latest funding stage is Venture round.
Diabeloop offers: Development and commercialization of AI-powered medical devices for diabetes management.
Top alternatives and competitors to Diabeloop include MicroTech Medical, Valeritas, HME Square, MELLIsim, Intuity Medical, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Diabeloop and MicroTech Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Diabeloop, https://bouncewatch.com/company/diabeloop, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout